📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Therapeutic targets and new directions for antibodies developed for ovarian cancer. (2016)

First Author: Bax HJ

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/19420862.2016.1219005

PubMed Identifier: 27494775

Publication URI: http://europepmc.org/abstract/MED/27494775

Type: Journal Article/Review

Volume: 8

Parent Publication: mAbs

Issue: 8

ISSN: 1942-0862